4//SEC Filing
Hineline Lawrence J. 4
Accession 0000950170-24-028819
CIK 0001567514other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:58 PM ET
Size
7.0 KB
Accession
0000950170-24-028819
Insider Transaction Report
Form 4
Hineline Lawrence J.
VP of Finance, CFO & Secretary
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-03-06−13,132→ 26,266 total→ Common Stock (13,132 underlying) - Exercise/Conversion
Common Stock
2024-03-06+13,132→ 13,132 total
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]On March 6, 2023, the reporting person was granted 39,398 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeother
Related Parties
1- filerCIK 0001585697
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 5:58 PM ET
- Size
- 7.0 KB